Drugs: Marketing

(asked on 5th July 2018) - View Source

Question to the Department of Health and Social Care:

To ask Her Majesty's Government what discussions have been held between the Department of Health and Social Care and the Department for Business, Energy and Industrial Strategy about the impact of the fee structure introduced by SecurMed, the UK’s National Medicines Verification Organisation, on small and medium-sized enterprises.


Answered by
Lord O'Shaughnessy Portrait
Lord O'Shaughnessy
This question was answered on 19th July 2018

There have been no specific discussions about the impact of SecurMed’s fee structure.

The Department and the Medicines and Healthcare products Regulatory Agency are responsible for supervising SecurMed and ensuring that they are complying with the regulation in a fair and proportionate way.

Reticulating Splines